Precision Business Insights
Portfolio

 

Research Reports

Thrombocytopenia Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Thrombocytopenia Treatment Market By Drug Class (Lysosomal Enzyme, Platelet Stimulating Agents, and Glucocorticoids), By Disease Indication (Leukemia, Hemolytic Uremic Syndrome, Immune Thrombocytopenia, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography.

 

Market Outline: Thrombocytopenia Treatment Market

 

Thrombocytopenia is the condition wherein which the patient has a low platelet count. The root cause for the thrombocytopenia are the platelet splenic sequestration, inefficiency in the production of the platelets and the destruction of the platelets. Thrombocytopenia is either inherited or acquired. It usually occurs owing to various disorders such as leukemia and immune system related conditions. This is commonly found in both adults and children. In thrombocytopenia condition show very less symptoms and is mild. In some cases, the count of the platelets is so low that it causes dangerous internal bleeding, as the patient affected with the thrombocytopenia leads to delayed blood clotting or sometimes no blood clotting.

 

Market Dynamics: Thrombocytopenia Treatment Market

 

Increase in the prevalence of thrombocytopenia all across the globe and rising count of the chronic hepatitis C cases, which causes the risk of thrombocytopenia are likely to drive the growth of the market. The growing government support by financial aids to the patients in developing and underdeveloped countries expected to drive the market revenue growth over forecast period. However, the stringent government regulations for approvals of newer treatments and increasing introduction of the generic drugs may hinder the growth of the market.

 

Global thrombocytopenia treatment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Scope: Thrombocytopenia Treatment Market

Thrombocytopenia treatment market is segmented based on the drug class, disease indication, and distribution channel

Based on the drug class, the market is segmented into the following:

  • Lysosomal Enzyme
  • Platelet Stimulating Agent
  • Glucocorticoids

 

Based on the disease indication, the market is segmented into the following:

  • Leukemia
  • Hemolytic Uremic Syndrome
  • Immune Thrombocytopenia
  • Others

 

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Regional Analysis: 

 

Geographically, global thrombocytopenia treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America thrombocytopenia treatment market is growing due to increase in the prevalence of thrombocytopenia. The deep-rooted healthcare infrastructure is also anticipated to drive the growth of the market in the region. The awareness among the patient population regarding the new treatment methods is likely to enhance the growth of the market in the region. The adoption of the new treatment procedures by the patient pool is boosting the growth of the thrombocytopenia treatment market in the region.

 

Competition Assessment: Thrombocytopenia Treatment Market

  • Merck & Co., Inc. (U.S)
  • Bristol-Myers Squibb Company (U.S)
  • ViroMed Co., Ltd (South Korea)
  • Rigel Pharmaceuticals, Inc. (U.S)
  • Shionogi & Co., Ltd. (Japan)
  • Cellerant Therapeutics, Inc. (U.S)

 

Notable Market Developments:

  • In February 2018, Shionogi & Co., Ltd announced that the New Drug Application (NDA) for lusutrombopag (S-888711), an investigational, once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, has been accepted for filing and has been granted Priority Review by the U.S. Food & Drug Administration (FDA)

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0

Table of Content

 

  1. Executive Summary
  2. Global Thrombocytopenia Treatment Market Introduction
    • Global Thrombocytopenia Treatment Market – Taxonomy
    • Global Thrombocytopenia Treatment Market –Definitions
      • Drug Class
      • Disease Indication
      • Distribution Channel
  1. Global Thrombocytopenia Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Thrombocytopenia Treatment Market Dynamic Factors – Impact Analysis
    • Global Thrombocytopenia Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Thrombocytopenia Treatment Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Thrombocytopenia Treatment Market, By Drug Class, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Lysosomal Enzyme
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Platelet Stimulating Agent
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Glucocorticoids
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Thrombocytopenia Treatment Market Forecast, By Disease Indication,2013 – 2017 and Forecast, 2018 – 2024
    • Leukemia
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hemolytic Uremic Syndrome
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Immune Thrombocytopenia
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Thrombocytopenia Treatment Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Thrombocytopenia Treatment Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Thrombocytopenia Treatment Market – Opportunity Analysis Index, By Drug Class, By Disease Indication, By Distribution Channel and Region, 2018 – 2024
  2. North America Thrombocytopenia Treatment MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Lysosomal Enzyme
      • Platelet Stimulating Agent
      • Glucocorticoids
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Hemolytic Uremic Syndrome
      • Immune Thrombocytopenia
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Thrombocytopenia Treatment Market – Opportunity Analysis Index, By Drug Class, By Disease Indication, By Distribution Channel and Country, 2018 – 2024
    • North America Thrombocytopenia Treatment Market Dynamics – Trends
  3. Europe Thrombocytopenia Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Lysosomal Enzyme
      • Platelet Stimulating Agent
      • Glucocorticoids
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Hemolytic Uremic Syndrome
      • Immune Thrombocytopenia
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Thrombocytopenia Treatment Market – Opportunity Analysis Index, By Drug Class, By Disease Indication, By Distribution Channel and Country, 2018 – 2024
    • Europe Thrombocytopenia Treatment Market Dynamics – Trends
  4. Asia-Pacific Thrombocytopenia Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Lysosomal Enzyme
      • Platelet Stimulating Agent
      • Glucocorticoids
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Hemolytic Uremic Syndrome
      • Immune Thrombocytopenia
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Thrombocytopenia Treatment Market – Opportunity Analysis Index, By Drug Class, By Disease Indication, By Distribution Channel and Country, 2018 – 2024
    • Asia-Pacific Thrombocytopenia Treatment Market Dynamics – Trends
  5. Latin America Thrombocytopenia Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Lysosomal Enzyme
      • Platelet Stimulating Agent
      • Glucocorticoids
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Hemolytic Uremic Syndrome
      • Immune Thrombocytopenia
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Thrombocytopenia Treatment Market – Opportunity Analysis Index, By Drug Class, By Disease Indication, By Distribution Channel and Country, 2018 – 2024
    • Latin America Thrombocytopenia Treatment Market Dynamics – Trends
  6. Middle East and Africa Thrombocytopenia Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Class Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Lysosomal Enzyme
      • Platelet Stimulating Agent
      • Glucocorticoids
    • Disease Indication Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Leukemia
      • Hemolytic Uremic Syndrome
      • Immune Thrombocytopenia
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Thrombocytopenia Treatment Market – Opportunity Analysis Index, By Drug Class, By Disease Indication, By Distribution Channel and Country, 2018 – 2024
    • MEA Thrombocytopenia Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Merck & Co., Inc. (U.S)
      • Bristol-Myers Squibb Company (U.S)
      • ViroMed Co., Ltd (South Korea)
      • Rigel Pharmaceuticals, Inc. (U.S)
      • Shionogi & Co., Ltd. (Japan)
      • Cellerant Therapeutics, Inc. (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Ask An Analyst

 

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials

Contact SalesTOLL FREE: +1-866-598-1553